Startup Ranking
Search
About Us
How It Works
Top Ranking
Countries
SR Faster Approval
SR Booster
SR AutoRankr
SR Premium Profile
SR Advertising
SR Ranko
New Startups
Create Startup
What is a startup?
How It Works
Blog
Log In
Search
Products
SR Faster Approval
Join our startup ranking in less than 24 hours.
SR Booster
Boost your startup's visibility & SEO.
SR Premium Profile
Upgrade your startup listing & enhance your credibility.
SR Advertising
Get your startup in front of founders and potential users.
SR AutoRankr
Automate content generation for your startup.
SR Ranko
Turn scattered startup information into focused action.
Top Ranking
Countries
New Startups
Blog
Create Startup
Log In
Posticy
Boost your SEO with Backlinks that are worth it
YOUR AD HERE
SR Ranko
Turn scattered startup information into focused action.
YOUR AD HERE
SR Booster
Submit your startup to 120+ top directories.
YOUR AD HERE
Company
Location:
United States
,
California
Follow
Edit
Upgrade
Company
Company Rank
0
Country Rank
0
SR Score
0
SR Web
0
SR Social
0
Tags
Biotechnology
Medical
Therapeutics
Ceptaris Therapeutics
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
Acquired
by
Actelion Pharmaceuticals
on
July 31, 2013
Website: https://www.ceptaris.com
Founded: January 01, 2002
Social:
SR Traffic - Month
Visits
0
Views/visit
1.00
Ahrefs
Domain Rating
0.00
Ceptaris Therapeutics Competitors
Add Competitor
Startup
Industry
Description
Vivodyne
Healthcare Equipment & Services
Discovers life-changing drugs and cellular therapies - Vivodyne accelerates the discovery of cures to hum ...
Chefaa
Pharmaceuticals & Biotechnology
On-Demand Smart Medicine System - Chefaa is an on-demand smart medicine system that ...
NowServing
Healthcare Equipment & Services
Weโre bridging the gap between Doctors & Patients - Find the doctor you need & book online appointment ...
View more competitors
»
Ceptaris Therapeutics Funding
Add Funding
Date
Round
Amount
Investors
Jun 05, 2012
Series D
$ 10,000,000
Palo Alto Investors
BioAdvance
Vivo Capital
Aperture Venture Partners
Osage Venture Partners
Third Point Ventures
Burrill & Company
Feb 21, 2012
Debt Financing
$ 15,000,000
Oxford Finance Corporation
Silicon Valley Bank
Nov 14, 2006
Series B
$ 4,500,001
Osage Venture Partners
Tdh Capital
BioAdvance
Ben Franklin Technology Partners of Southeastern Pennsylvania
View more funding rounds
»
Ceptaris Therapeutics Acquisitions
Add Acquisition
Date
Acquired
Amount
There are no acquisitions.
Ceptaris Therapeutics Products
Add Product
Product
Stage
Description
There are no products.
Ceptaris Therapeutics Team
Add Team Member
Person
Role
Period
There are no team members.
Ceptaris Therapeutics News
Add News
Date
Title
There are no news.
Ceptaris Therapeutics Statistics
Last Week
Rank
SR Score
Likes
Followers
Last Month
Rank
SR Score
Likes
Followers